TrialBMC complementary and alternative medicine2016

Effects of Tangshen Formula on urinary and plasma liver-type fatty acid binding protein levels in patients with type 2 diabetic kidney disease: post-hoc findings from a multi-center, randomized, double-blind, placebo-controlled trial investigating the efficacy and safety of Tangshen Formula in patients with type 2 diabetic kidney disease.

Xin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.